CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000DJ1CT38

Market Closed - Deutsche Boerse AG 15:34:23 2024-06-26 EDT
56.41 EUR -0.46% Intraday chart for CAPPED BONUSZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month-0.79%
1 month+0.23%
Date Price Change
24-06-26 56.41 -0.46%
24-06-25 56.67 +0.39%
24-06-24 56.45 +1.31%
24-06-21 55.72 -0.77%
24-06-20 56.15 +0.39%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 03:34 pm

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer DZ BANK
WKN DJ1CT3
ISINDE000DJ1CT38
Date issued 2023-04-27
Strike 60
Maturity 2024-09-20 (86 Days)
Parity 1 : 1
Emission price 49.41
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 57.6
Lowest since issue 36.51
Spread 0.1
Spread %0.18%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.68 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.03%
Consensus